Thomas G Boyce

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Immune Response

Top Venues

Human vaccines & immunotherapeutics

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Thomas G Boyce, David L McClure, Kayla E Hanson, Matthew F Daley, Malini B DeSilva, Stephanie A Irving, Lisa A Jackson, Nicola P Klein, Bruno J Lewin, Joshua T B Williams, Jonathan Duffy, Michael M McNeil, Eric S Weintraub, Edward A Belongia
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and drug safety 33 (8) (2024)